Cargando…

Hydroxychloroquine and QT prolongation: reassuring data in approved indications

Detalles Bibliográficos
Autores principales:	Pareek, Anil, Sharma, Tarun S, Mehta, Ravi Tejraj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Letter to the Editor (Other)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607156/ https://www.ncbi.nlm.nih.gov/pubmed/33173848 http://dx.doi.org/10.1093/rap/rkaa044

Ejemplares similares

Comment on: Incidence of blindness in a population of rheumatic patients treated with hydroxychloroquine
por: Pareek, Anil, et al.
Publicado: (2019)

An antiarrhythmic approach to hydroxychloroquine-induced QT prolongation
por: Yetkin, E., et al.
Publicado: (2020)

Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen
por: Pareek, Anil, et al.
Publicado: (2020)

Chlorthalidone, not hydrochlorothiazide, is the right diuretic for comparison
por: Mehta, Ravi Tejraj, et al.
Publicado: (2018)

Compelling therapy of LVH: straight (and not-so-straight) inferences from evidence
por: Mehta, Ravi Tejraj, et al.
Publicado: (2019)

Hydroxychloroquine and QT Prolongation in Older Patients with Rheumatic Diseases: Who is afraid of the Boogeyman? We are not!
por: Castagna, Alberto, et al.
Publicado: (2020)

REVEAL Study: Reveals the Limitations of Cholesteryl Ester Transfer Protein Inhibition
por: Pareek, Anil, et al.
Publicado: (2018)

QT prolongation with methadone
por: Dhamija, Radhika, et al.
Publicado: (2008)

Hydroxychloroquine-associated QT interval prolongation
Publicado: (2020)

QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020)

Hydroxychloroquine: risk of QT prolongation and drug interactions
Publicado: (2020)

Azithromycin/hydroxychloroquine: Prolongation of the QT interval: case report
Publicado: (2020)

False Reassurance Based on Non-Significant Results
por: Altman, Douglas G.
Publicado: (2017)

HCQ induced QT prolongation- Primum non nocere
por: Mahendran, A.J., et al.
Publicado: (2020)

Discordant results about QT prolongation in patients with Turner syndrome
por: Keskin, Berhan, et al.
Publicado: (2018)

Does pulmonary vein isolation prolong QT-interval?— Authors’ reply
por: Hermans, Ben J M, et al.
Publicado: (2021)

Hydroxychloroquine/Azithromycin Therapy and QT Prolongation in Hospitalized Patients With COVID-19
por: O’Connell, Thomas F., et al.
Publicado: (2021)

Hydroxychloroquine: QT prolongation due to off-label use: case report
Publicado: (2022)

An Issue Waiting to be Clarified: Effects of the QT Prolonging Drugs on Tp-e Interval
por: Yiginer, Omer, et al.
Publicado: (2015)

System biological investigations of hydroxychloroquine and azithromycin targets and their implications in QT interval prolongation
por: Khan, Abdul Arif, et al.
Publicado: (2020)

Hydroxychloroquine: Prolonged QT interval following off label use: case report
Publicado: (2020)

Prolongation of QT interval due to hydroxychloroquine overdose used in COVID-19 treatment
por: Aksel, Gökhan, et al.
Publicado: (2020)

Azithromycin/hydroxychloroquine: QT prolongation following off label use: case report
Publicado: (2022)

Hydroxychloroquine: QT interval prolongation following off-label use: case report
Publicado: (2022)

Lexique risque: sécurité, financement, assurance, réassurance
por: Lesobre, Jacques, et al.
Publicado: (2008)

Main challenges of electrolyte imbalance in older patients with COVID-19 and risk of QT prolongation
por: Rezazadeh, Amir, et al.
Publicado: (2021)

Main challenges of electrolyte imbalance in older patients with COVID-19 and risk of QT prolongation. Response
por: Bonanad, Clara, et al.
Publicado: (2021)

Corrected QT interval prolongation after ganglionated plexus ablation: myth or reality?—Authors’ reply
por: Hermans, Ben J M, et al.
Publicado: (2021)

The 12-Lead ECG in COVID-19: QT Prolongation Predicts Outcome
por: Akhtar, Zaki, et al.
Publicado: (2021)

Prolonged QT Interval in a Patient With Coronavirus Disease-2019: Beyond Hydroxychloroquine and Azithromycin
por: Anupama, B K, et al.
Publicado: (2020)

Azithromycin/hydroxychloroquine: Prolonged corrected QT following off label use: case report.
Publicado: (2020)

Azithromycin/hydroxychloroquine: Prolonged QT interval during off label use: case report
Publicado: (2021)

Which QTc correction formulae (Bazett, Framingham, or Fridericia) to use for Hydroxychloroquine induced QTc prolongation?
por: Gupta, Anunay, et al.
Publicado: (2020)

QT interval prolongation in geriatric patients treated for SARS-COV-2 infection: OCTA-COVID study()()
por: Garmendia-Prieto, Blanca, et al.
Publicado: (2021)

Further reassurance on the safety profile of colchicine
por: Hashkes, Philip J.
Publicado: (2020)

QT Interval Prolongation as a Biomarker for Torsades de Pointes and Sudden Death in Drug Development
por: Sides, Gregory D.
Publicado: (2002)

Azithromycin/hydroxychloroquine interaction: QT interval prolongation following off-label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Corrected QT-interval prolongation following off label use: case report
Publicado: (2020)

QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin
por: Chorin, Ehud, et al.
Publicado: (2020)

Hydroxychloroquine: Electrical storm and QT interval prolongation following off-label use: case report
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jbrh38u719qivdv0dooq5fh0nk